Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when OptimizeRx Corp publishes a filing, an earnings call transcript or a press release.

Get OPRX alerts

About Stephen Silvestro

Stephen Silvestro is recorded as CEO at OptimizeRx Corp (OPRX) since March 10, 2025 and Board Member at OptimizeRx Corp (OPRX) since January 1, 2025. The newest filing on record that lists Stephen Silvestro as Board Member at OptimizeRx Corp (OPRX) is dated April 30, 2026. OptimizeRx Corp reported in an 8-K filed June 12, 2026 that Stephen Silvestro was appointed director, effective June 9, 2026. OptimizeRx Corp reported in an 8-K filed March 10, 2025 that Stephen Silvestro was appointed Chief Executive Officer, effective March 10, 2025. OptimizeRx Corp reported in an 8-K filed December 23, 2024 that Stephen Silvestro was appointed interim CEO, effective December 31, 2024. The proxy statement of OptimizeRx Corp reports total compensation of $2,717,717 for Stephen Silvestro in fiscal 2025, including a base salary of $500,000. Disclosed compensation is on record for 8 fiscal years. Stephen Silvestro has spoken on 2 earnings calls across 1 company, most recently for OptimizeRx Corp on August 12, 2026. OptimizeRx Corp is classified in the Health Information Services industry within the Healthcare sector. Other leadership on record at OptimizeRx Corp includes William Febbo (CEO and Board Member), William J. Febbo (CEO and Board Member), Lynn O'Connor Vos (Chairman and Board Member) and 7 others.

“The following nominees were each elected to serve as director for a term that expires at the next annual meeting of shareholders and until his or her successor has been elected and qualified or until his or her earlier death, resignation or removal based upon the following votes:”
OptimizeRx Corp Form 8-K, filed June 12, 2026 · Read the filing
“On March 10, 2025, OptimizeRx Corporation (the “Company”) announced that Stephen Silvestro has been appointed to serve as the Company’s Chief Executive Officer, effective as of March 10, 2025 (the “Effective Date”).”
OptimizeRx Corp Form 8-K, filed March 10, 2025 · Read the filing

Stephen Silvestro on recent calls

“We right now don't have any expectation baked into the back half for that large client coming back, but we are starting to see some progress around it that will definitely positively impact the back half. how much we're not really prepared to say at this point, but discussions are open and we're, you know, we're…”
CEO, OPRX 2nd Quarter 2026 Earnings Conference Call ·
“Thank you, Operator, and good afternoon to everyone joining us for today's first quarter 2026 earnings call. We delivered a solid start to the year, which exceeded consensus estimates on the top and bottom line.”
CEO, OptimizeRx Corp Q1 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at OptimizeRx Corp

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 OptimizeRx Corp (OPRX) $500,000 $2,717,717
2024 OptimizeRx Corp (OPRX) $400,000 $973,132
2023 OptimizeRx Corp (OPRX) $384,583 $970,357
2022 OptimizeRx Corp (OPRX) $350,000 $1,558,637
2021 OptimizeRx Corp (OPRX) $330,000 $1,243,902
2020 OptimizeRx Corp (OPRX) $300,000 $866,190
2019 OptimizeRx Corp (OPRX) $188,821 $1,120,199
2018 OptimizeRx Corp (OPRX) — —

Recent activity